Paxlovid (nirmatrelvir/ritonavir)

pCPA File Number: 22592
Negotiation Status:
Concluded with an LOI
Indication(s):
Mild-to-moderate COVID-19, treatment
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
SR0808-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: